|
시장보고서
상품코드
1890926
컴피턴트 셀 시장 : 세포 유형별, 생물 유형별, 용도별, 컴피턴시 레벨별, 최종사용자별, 지역별Competent Cells Market, By Cell Type, By Organism Type, By Application, By Competency Level, By End User, By Geography |
||||||
컴피턴트 셀 시장은 2025년에 24억 7,000만 달러로 추정되며, 2032년까지 48억 7,000만 달러에 달할 것으로 예측됩니다. 2025-2032년 CAGR 10.2%로 성장할 것으로 전망되고 있습니다.
| 리포트 내용 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2024년 | 2025년 시장 규모 : | 24억 7,000만 달러 |
| 과거 데이터 대상 기간 : | 2020-2024년 | 예측 기간 : | 2025-2032년 |
| 예측 기간인 2025-2032년의 CAGR : | 10.20% | 2032년 예측 : | 48억 7,000만 달러 |
세계 컴피턴트 셀 시장은 생명공학 및 제약 산업에서 중요한 부분을 차지하고 있으며, 분자생물학 응용 및 유전공학 공정의 기본 툴로 활용되고 있습니다. 컴피턴트 셀은 화학적 또는 물리적 처리를 통해 DNA에 대한 투과성을 높인 박테리아 세포로, 연구자가 형질전환 과정을 통해 외래 유전물질을 도입할 수 있게 해줍니다. 이러한 특수 세포는 복제, 단백질 발현, 플라스미드 증폭 및 현대 생명공학 연구개발의 기반이 되는 다양한 재조합 DNA 기술에서 필수적인 역할을 담당하고 있습니다.
이 시장은 화학적 유능세포, 전기적 유능세포 등 일상적인 복제에서 고효율 형질전환에 이르기까지 특정 용도에 맞게 설계된 다양한 유능세포를 포괄하고 있습니다. 유전체 연구의 확대, 맞춤형 의료의 추진, 생명공학 혁신에 따라 신뢰성과 효율성을 겸비한 컴피턴트 셀 시스템에 대한 수요는 전 세계에서 급증하고 있습니다. 학술연구기관, 제약회사, 바이오테크놀러지 기업, 위탁연구기관(CRO)이 주요 최종사용자로 구성되어 있으며, 치료제 개발 및 과학 연구에서 획기적인 발견을 촉진하는 분자 복제 툴 및 유전자 조작 기술에 대한 지속적인 수요를 통해 시장 성장을 주도하고 있습니다.
시장 역학
세계 컴피턴트 셀 시장은 연구 및 상업적 응용 분야 모두에서 확장을 촉진하는 여러 가지 주요 촉진요인에 의해 주도되고 있습니다. 유전체학 및 단백질체학 연구에 대한 투자 증가와 혁신적인 치료 솔루션을 필요로 하는 유전성 질환 증가 추세는 시장 발전의 주요 성장 촉매제가 되고 있습니다. 합성생물학 접근법, CRISPR-Cas9 유전자 편집 기술, 맞춤형 의료 구상의 확산으로 복잡한 유전자 조작을 가능하게 하는 고품질 컴피턴트 셀에 대한 수요가 크게 증가하고 있습니다. 또한 특히 신흥 경제국에서의 생명공학 분야의 확대는 시장 침투와 매출 창출의 큰 기회를 창출하고 있습니다. 그러나 유전자 연구와 생명공학 응용을 규제하는 엄격한 법적 규제 프레임워크 등 눈에 띄는 제약도 존재합니다. 이는 제품 승인 지연과 제조업체의 컴플라이언스 비용 증가로 이어질 수 있습니다.
특히 예산이 한정된 소규모 연구기관의 경우, 역량 셀의 콜드체인 물류 및 보관 요건 유지에 따른 높은 비용이 또 다른 도전이 될 수 있습니다. 또한 컴피턴트 셀을 다루는 데 있으며, 기술적 복잡성과 전문 지식이 필요하므로 경험이 부족한 연구자들이 채용하는 것을 제한할 수 있습니다. 이러한 제약에도 불구하고 신약개발 프로그램에 대한 관심 증가, CRO(위탁연구기관)에 연구 활동을 위탁하는 추세, 바이오연료 생산 및 의약품 제조를 포함한 산업 바이오테크놀러지 공정에서 컴피턴트셀의 적용 확대 등의 요인으로 인해 큰 기회가 창출되고, 시장은 지속적인 성장 궤도에 오를 것으로 예측됩니다. 시장은 지속적인 성장 궤도에 오를 것으로 예측됩니다.
본 조사의 주요 특징
- 이 보고서는 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(10억 달러)와 예측 기간(2025-2032년)의 연평균 성장률(CAGR)을 나타내는 세계 컴피턴트 셀(Competent Cells) 시장에 대한 상세한 분석을 제공합니다.
- 또한 다양한 부문의 잠재적 매출기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명합니다.
- 시장 성장 촉진요인, 제약요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략에 대한 중요한 정보를 제공합니다.
- 이 보고서에서는 기업 개요, 제품 포트폴리오, 주요 특징, 재무 실적, 전략 등 다양한 매개 변수를 기반으로 전 세계 컴피턴트 셀 시장의 주요 업체를 프로파일링합니다.
- 이 보고서는 마케팅 담당자 및 기업 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 이 세계 컴피턴트 셀 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 컴피턴트 셀 시장 분석에 사용된 다양한 전략 매트릭스를 통해 쉽게 의사결정을 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 범위
- 리포트 개요
- 시장 정의와 범위
- 개요
제3장 시장 역학, 규제 및 동향 분석
- 시장 역학
- 촉진요인
- 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 환경
- 제품 발매·승인
- PEST 분석
- Porter의 산업 분석
- 합병·인수의 동향
- 업계 동향
제4장 세계의 컴피턴트 셀 시장 : 세포 유형별, 2020-2032년
- 화학적 컴피턴트 셀
- 전기 컴피턴트 셀
- 초컴피턴트 셀
제5장 세계의 컴피턴트 셀 시장 : 생물 유형별, 2020-2032년
- 세균 컴피턴트 셀
- 효모 컴피턴트 셀
- 포유류 컴피턴트 셀
제6장 세계의 컴피턴트 셀 시장 : 용도별, 2020-2032년
- 분자 클로닝 및 서브 클로닝
- 재조합 단백질 발현
- 플라스미드 및 라이브러리 구축(cDNA, 게놈, 파지, BAC/YAC 라이브러리)
- 돌연변이 도입과 지향 진화
- CRISPR/Cas 및 유전자 편집 워크플로우
- 합성생물학 및 대사 공학
- 바이러스 벡터 구축 및 포장 지원
- 기타 용도(예 : 기능 유전체학, 경로 스크리닝)
제7장 세계의 컴피턴트 셀 시장 : 컴피턴시 레벨별, 2020-2032년
- 고효율 컴피턴트 셀
- 중효율 컴피턴트 셀
- 저효율 컴피턴트 셀
제8장 세계의 컴피턴트 셀 시장 : 최종사용자별, 2020-2032년
- 학술·연구기관
- 바이오테크놀러지 및 바이오의약품 기업
- 수탁 조사기관(CRO)
- 진단·임상 연구 연구소
- 산업 미생물학 및 합성생물학 기업
- 정부 및 비영리 연구기관
제9장 세계의 컴피턴트 셀 시장 : 지역별, 2020-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카 국가
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동 국가
- 아프리카
- 남아프리카공화국
- 북아프리카
- 중앙아프리카
제10장 경쟁 구도
- Thermo Fisher Scientific Inc
- Merck KGaA Sigma Aldrich
- Agilent Technologies Inc
- Takara Bio Inc
- New England Biolabs Inc
- Promega Corporation
- QIAGEN NV
- Zymo Research Corp
- Bio Rad Laboratories Inc
- GenScript Biotech Corporation
- OriGene Technologies Inc
- Lucigen brand of LGC Biosearch Technologies
- HiMedia Laboratories Pvt Ltd
- Intact Genomics Inc
- Scarab Genomics LLC
제11장 애널리스트의 권장사항
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map
제12장 참고 문헌 및 조사 방법
- 참고 문헌
- 조사 방법
- 출판사 소개
Competent Cells Market is estimated to be valued at USD 2.47 Bn in 2025 and is expected to reach USD 4.87 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 2.47 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 10.20% | 2032 Value Projection: | USD 4.87 Bn |
The global competent cells market represents a critical segment within the biotechnology and pharmaceutical industry, serving as fundamental tools for molecular biology applications and genetic engineering processes. Competent cells are bacterial cells that have been chemically or physically treated to increase their permeability to DNA, enabling researchers to introduce foreign genetic material through transformation procedures. These specialized cells play an indispensable role in cloning, protein expression, plasmid propagation, and various recombinant DNA technologies that form the backbone of modern biotechnology research and development.
The market encompasses various types of competent cells, including chemically competent cells and electrocompetent cells, each designed for specific applications ranging from routine cloning to high-efficiency transformations. With the expanding scope of genomics research, personalized medicine initiatives, and biotechnology innovations, the demand for reliable and efficient competent cell systems continues to surge globally. Academic research institutions, pharmaceutical companies, biotechnology firms, and contract research organizations constitute the primary end users driving market growth through their continuous need for molecular cloning tools and genetic manipulation technologies that facilitate breakthrough discoveries in therapeutic development and scientific research.
Market Dynamics
The global competent cells market is propelled by several key drivers that collectively fuel its expansion across research and commercial applications. The increasing investment in genomics and proteomics research, coupled with the growing prevalence of genetic disorders requiring innovative therapeutic solutions, serves as a primary growth catalyst for market advancement. The rising adoption of synthetic biology approaches, CRISPR-Cas9 gene editing technologies, and personalized medicine initiatives significantly amplifies the demand for high-quality competent cells capable of facilitating complex genetic manipulations. Additionally, the expanding biotechnology sector, particularly in emerging economies, creates substantial opportunities for market penetration and revenue generation. However, the market faces notable restraints including stringent regulatory frameworks governing genetic research and biotechnology applications, which can delay product approvals and increase compliance costs for manufacturers.
The high cost associated with maintaining cold chain logistics and storage requirements for competent cells poses additional challenges, particularly for smaller research institutions with limited budgets. Furthermore, the technical complexity involved in handling competent cells and the requirement for specialized expertise may limit adoption among novice researchers. Despite these constraints, significant opportunities emerge from the increasing focus on drug discovery and development programs, the growing trend of outsourcing research activities to contract research organizations, and the expanding applications of competent cells in industrial biotechnology processes including biofuel production and pharmaceutical manufacturing, positioning the market for sustained growth trajectory.
Key Features of the Study
- This report provides in-depth analysis of the global competent cells market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global competent cells market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc, Merck KGaA Sigma Aldrich, Agilent Technologies Inc, Takara Bio Inc, New England Biolabs Inc, Promega Corporation, QIAGEN NV, Zymo Research Corp, Bio Rad Laboratories Inc, GenScript Biotech Corporation, OriGene Technologies Inc, Lucigen brand of LGC Biosearch Technologies, HiMedia Laboratories Pvt Ltd, Intact Genomics Inc, and Scarab Genomics LLC
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global competent cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global competent cells market
Market Segmentation
- Cell Type Insights (Revenue, USD Bn, 2020 - 2032)
- Chemically Competent Cells
- Electrocompetent Cells
- Ultracompetent Cells
- Organism Type Insights (Revenue, USD Bn, 2020 - 2032)
- Bacterial Competent Cells
- Yeast Competent Cells
- Mammalian Competent Cells
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Molecular Cloning and Subcloning
- Recombinant Protein Expression
- Plasmid and Library Construction (cDNA, genomic, phage, BAC/YAC libraries)
- Mutagenesis and Directed Evolution
- CRISPR/Cas and Genome Editing Workflows
- Synthetic Biology and Metabolic Engineering
- Viral Vector Construction and Packaging Support
- Other Applications (e.g., functional genomics, pathway screening)
- Competency Level Insights (Revenue, USD Bn, 2020 - 2032)
- High Efficiency Competent Cells
- Moderate Efficiency Competent Cells
- Low Efficiency Competent Cells
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Academic and Research Institutes
- Biotechnology and Biopharmaceutical Companies
- Contract Research Organizations (CROs)
- Diagnostic and Clinical Research Laboratories
- Industrial Microbiology and Synthetic Biology Companies
- Government and Non-Profit Research Organizations
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific Inc
- Merck KGaA Sigma Aldrich
- Agilent Technologies Inc
- Takara Bio Inc
- New England Biolabs Inc
- Promega Corporation
- QIAGEN NV
- Zymo Research Corp
- Bio Rad Laboratories Inc
- GenScript Biotech Corporation
- OriGene Technologies Inc
- Lucigen brand of LGC Biosearch Technologies
- HiMedia Laboratories Pvt Ltd
- Intact Genomics Inc
- Scarab Genomics LLC
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Competent Cells Market, By Cell Type
- Global Competent Cells Market, By Organism Type
- Global Competent Cells Market, By Application
- Global Competent Cells Market, By Competency Level
- Global Competent Cells Market, By End User
- Global Competent Cells Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Competent Cells Market, By Cell Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Chemically Competent Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Electrocompetent Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ultracompetent Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Competent Cells Market, By Organism Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Bacterial Competent Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Yeast Competent Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Mammalian Competent Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Competent Cells Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Molecular Cloning and Subcloning
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Recombinant Protein Expression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Plasmid and Library Construction (cDNA, genomic, phage, BAC/YAC libraries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Mutagenesis and Directed Evolution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- CRISPR/Cas and Genome Editing Workflows
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Synthetic Biology and Metabolic Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Viral Vector Construction and Packaging Support
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Other Applications (e.g., functional genomics, pathway screening)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Competent Cells Market, By Competency Level, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- High Efficiency Competent Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Moderate Efficiency Competent Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Low Efficiency Competent Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Competent Cells Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biotechnology and Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diagnostic and Clinical Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Industrial Microbiology and Synthetic Biology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Government and Non-Profit Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Competent Cells Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Organism Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Competency Level, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Organism Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Competency Level, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Organism Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Competency Level, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Organism Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Competency Level, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Organism Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Competency Level, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Organism Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Competency Level, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Thermo Fisher Scientific Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA Sigma Aldrich
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takara Bio Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- New England Biolabs Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Promega Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN NV
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zymo Research Corp
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio Rad Laboratories Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GenScript Biotech Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- OriGene Technologies Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lucigen brand of LGC Biosearch Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HiMedia Laboratories Pvt Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Intact Genomics Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Scarab Genomics LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
